Filter
2917
Filtered Results: 2917
Text search:
Drug
Resistance
Featured
Recommendations
307
New Publications
748
Language
Document type
No document type
1629
Studies & Reports
453
Guidelines
442
Manuals
133
Strategic & Response Plan
106
Fact sheets
58
Training Material
48
Situation Updates
15
Infographics
13
Resource Platforms
7
Online Courses
5
Brochures
3
Videos
3
App
2
Countries / Regions
India
156
Global
95
South Africa
81
Kenya
79
Western and Central Europe
75
Ethiopia
61
Uganda
53
Tanzania
51
Nepal
48
Eastern Europe
47
Africa
45
Zambia
42
Nigeria
40
Latin America and the Carribbean
38
Liberia
37
Sierra Leone
34
Malawi
32
Namibia
32
Ghana
31
Philippines
31
Myanmar / Burma
30
Bangladesh
29
Rwanda
28
Asia
26
Cambodia
23
Lesotho
22
South–East Asia Region
22
Zimbabwe
20
Ukraine
19
Senegal
19
Russia
19
Indonesia
19
Botswana
14
Congo, Democratic Republic of
13
Cameroon
12
Mozambique
12
Colombia
11
Venezuela
10
Syria
9
Thailand
8
Albania
8
Burkina Faso
8
West and Central Africa
8
Middle East and North Africa
8
Eastern Europe and Central Asia
8
Eswatini/ Swaziland
8
Haiti
7
Germany
7
East and Southern Africa
7
Argentina
7
Pakistan
7
Tajikistan
6
USA
6
Vietnam
6
Benin
5
China
5
Laos
5
Guinea
5
Georgia
5
El Salvador
4
Iran
4
Peru
4
Western Pacific Region
4
Brazil
4
Sri Lanka
4
Sudan
4
Iraq
4
North Macedonia
3
Estonia
3
Afghanistan
3
Jordan
3
Paraguay
3
North America
3
Uruguay
3
Lebanon
3
Central African Republic
3
Mali
3
Bhutan
3
South Sudan
3
Somalia
3
Timor Leste/ East Timor
2
Mexico
2
Morocco
2
Armenia
2
Saudi Arabia
2
Gabon
2
France
2
Tunisia
2
Côte d’Ivoire / Ivory Coast
2
Papua New Guinea
2
Nicaragua
2
Moldova
2
Yemen
2
Honduras
2
Libya
2
Ecuador
2
Madagascar
2
Guatemala
2
Switzerland
1
Serbia
1
Turkey
1
Gambia
1
Kazakhstan
1
Canada
1
Fiji
1
Congo-Brazzaville
1
Niger
1
Qatar
1
Italy
1
Dominican Republic
1
Guinea-Bissau
1
Turkmenistan
1
Jamaica
1
Denmark
1
Belgium
1
Maldives
1
Mauritius
1
United Kingdom
1
Spain
1
Bolivia
1
Belize
1
Costa Rica
1
Oman
1
Panama
1
Egypt
1
Romania
1
Greece
1
Angola
1
Chad
1
Authors & Publishers
Publication Years
Category
Countries
1028
Clinical Guidelines
293
Public Health
119
Women & Child Health
81
Key Resources
72
Capacity Building
40
Pharmacy & Technologies
38
Annual Report MEDBOX
1
Toolboxes
TB
509
HIV
353
AMR
329
NTDs
119
Mental Health
113
Malaria
100
COVID-19
94
Pharmacy
74
Rapid Response
63
Caregiver
49
Planetary Health
48
NCDs
37
Ebola & Marburg
33
Global Health Education
32
Refugee
31
Health Financing Toolbox
21
Polio
17
Conflict
14
Cholera
13
Disability
11
Natural Hazards
8
Zika
5
Specific Hazards
3
Social Ethics
3
May 2018
HIV i-Base
ISSN 1475-2077 www.i-Base.info
Watch for out-of-date information
First questions
You and your doctor Resistance and adherence Treatment choices
PlosOne January 20, 2021
https://doi.org/10.1371/journal.pone.0241899
Antibiotic fixed dose combinations (FDCs) can have clinical advantages such as improving effectiveness and adherence to therapy. However, high use of potentially inappropriate FDCs has been reported, with implications for antim...
Review over the work and challenges of the Nigerian National Agency for Food and Drug Administration and Control (NAFDAC) in combatting counterfeiting of medicines in Nigeria.
This guide is a resource for physicians and other health care professionals who provide care and treatment to patients with drug-resistant tuberculosis.
These are two parallel guidelines, one for small hospitals and another one for large hospitals. In view of heavy burden of malaria and prevalence of drug resistant falciparum malaria in the South-East Asia Region, the guidelines were developed for use by medical personnel who treat severe malaria pa...
The Democratic Republic of Timor-Leste has the highest TB incidence rate in the South East Asian Region - 498 per 100,000, which is the seventh highest in the world. In Timor-Leste TB is the eighth most common cause of death.
The salient observations are as follows:
In 2018, 487 (12.5%) of the...
TB remains one of the world’s deadliest infectious diseases, second only to COVID-19, and drug-resistant TB strains are still a major concern. In the fight against TB, urgent investment is critical, especially in the context of the ongoing pandemic.
hese are two parallel guidelines, one for small hospitals and another one for large hospitals. In view of heavy burden of malaria and prevalence of drug resistant falciparum malaria in the South-East Asia Region, the guidelines were developed for use by medical personnel who treat severe malaria pat...
There is an urgent need for safer, simpler, more efficacious and accessible treatment regimens for all forms of TB. The development of Target Product Profiles for TB treatment regimens (referred to as Target Regimen Profiles or TRPs) seeks to guide the drug development process towards important regi...
The Updated guidelines on Management of tuberculosis in children and adolescents include new recommendations that cover diagnostic approaches for TB, shorter treatment for children with non-severe drug-susceptible TB, a new option for the treatment of TB meningitis, the use of bedaquiline and delama...
Most of the global burden of sepsis occurs in low- and middle-income countries (LMICs), but the prevalence and etiology of sepsis in LMICs are not well understood. In particular, the lack of laboratory infrastructure in many LMICs has historically precluded an assessment of the pathogens leading to ...
Co-trimoxazole is a fixed-dose combination of two antimicrobial drugs (sulfamethoxazole and trimethoprim) that covers a variety of bacterial, fungal and protozoan infections. Co-trimoxazole preventive therapy is a feasible, well tolerated and inexpensive intervention for people living with HIV to re...
sthma prevalence is increasing worldwide, and surveys indicate that most patients in developed and developing countries, including South Africa, do not receive optimal care and are therefore not well controlled. Standard management guidelines adapted to in-country realities are important to support ...
The WHO South-East Asia (SEA) Region bears a high burden of tuberculosis (TB) and MDR-TB. In 2015, the Region accounted for nearly 200 000 or 35% of the global estimated new RR/MDR-TB cases eligible for treatment. Extensively drug-resistant TB (XDRTB) has also been reported from s...
N Engl J Med 2022; 386:911-922, DOI: 10.1056/NEJMoa2104535
Four months of antituberculosis treatment was noninferior to 6 months of treatment in children with drug-susceptible, nonsevere, smear-negative tuberculosis (SHINE Study)
Review of International, Regional and National Policies and Legal Frameworks that Promote Migrants and Mobile Populations' Access to Health and Malaria Services in the Greater Mekong Subregion (Cambodia, Lao People's Democratic Republic, Myanmar, Thailand and Viet Nam)
Migrants and mobile popul...
Migrants and mobile popul...
The guidelines are aimed at clinical professionals directly involved with and responsible for the care of adults with HIV infection, and at community advocates responsible for promoting the best interests and care of HIV-positive adults. They should be read in conjunction with other published BHIVA ...
The goal of this addendum is to help management and staff
minimize the risk of TB transmission at facilities in resource limited settings in which a.) HIV-infected persons receive diagnosis, care, treatment,
and/or support, and b.) there is a high prevalence of HIV infection, both known
and...
The strategic framework gives guidance to public and private health facilities and health workers on compliance with standards relating to IPC practices. To further assist health facilities to implement the IPC strategic framework, this practical implementation manual has been developed in parallel ...
Global Tuberculosis Report 2022 Factsheet
recommended
The World Health Organization Global TB Report provides a comprehensive and up-to-date assessment of the TB epidemic, and progress in the response, at global, regional and country levels.
The 2022 edition features data on disease trends and the response to the epidemic from 215 countries and area...
